Gal4-p67MBP Citations (8)
Originally described in: Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK.Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J, Jaeger S, Erdjument-Bromage H, Tempst P, Spiegelman BM Genes Dev 2004 Feb 1;18(3):278-89. Epub 2004 Jan 26. PubMed Journal
Articles Citing Gal4-p67MBP
| Articles |
|---|
| ATG14 plays a critical role in hepatic lipid droplet homeostasis. Huang M, Zhang Y, Park J, Chowdhury K, Xu J, Lu A, Wang L, Zhang W, Ekser B, Yu L, Dong XC. Metabolism. 2023 Nov;148:155693. doi: 10.1016/j.metabol.2023.155693. Epub 2023 Sep 22. PubMed |
| Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer. Wright CA, Gordon ER, Cooper SJ. BMC Cancer. 2023 Nov 23;23(1):1137. doi: 10.1186/s12885-023-11645-0. PubMed |
| Dampened Regulatory Circuitry of TEAD1/ITGA1/ITGA2 Promotes TGFbeta1 Signaling to Orchestrate Prostate Cancer Progression. Cruz SP, Zhang Q, Devarajan R, Paia C, Luo B, Zhang K, Koivusalo S, Qin L, Xia J, Ahtikoski A, Vaarala M, Wenta T, Wei GH, Manninen A. Adv Sci (Weinh). 2024 Mar;11(11):e2305547. doi: 10.1002/advs.202305547. Epub 2024 Jan 2. PubMed |
| Functionally-instructed modifiers of response to ATR inhibition in experimental glioma. Walter B, Hirsch S, Kuhlburger L, Stahl A, Schnabel L, Wisser S, Haeusser LA, Tsiami F, Ploger S, Aghaallaei N, Dick AM, Skokowa J, Schmees C, Templin M, Schenke-Layland K, Tatagiba M, Nahnsen S, Merk DJ, Tabatabai G. J Exp Clin Cancer Res. 2024 Mar 12;43(1):77. doi: 10.1186/s13046-024-02995-z. PubMed |
| Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF. Sui XY, Ma XY, Hou Y, Cao SW, Wang ZQ, Jia LJ, Fan L, Shao ZM, Zhang WJ. Cell Biol Toxicol. 2024 Apr 23;40(1):24. doi: 10.1007/s10565-024-09864-7. PubMed |
| CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy. Qin M, Deng C, Wen L, Luo G, Meng Y. J Transl Med. 2024 May 30;22(1):516. doi: 10.1186/s12967-024-05235-2. PubMed |
| Genome-wide in vivo CRISPR screen identifies TGFbeta3 as actionable biomarker of palbociclib resistance in triple negative breast cancer. Poulet S, Dai M, Wang N, Yan G, Boudreault J, Daliah G, Guillevin A, Nguyen H, Galal S, Ali S, Lebrun JJ. Mol Cancer. 2024 Jun 3;23(1):118. doi: 10.1186/s12943-024-02029-4. PubMed |
| CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines. Merk DJ, Paul L, Tsiami F, Hohenthanner H, Kouchesfahani GM, Haeusser LA, Walter B, Brown A, Persky NS, Root DE, Tabatabai G. Genome Med. 2024 Jun 17;16(1):82. doi: 10.1186/s13073-024-01341-4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.